Search Results
Results found for "British Pharmacological Society"
- Dr. Oliver Hartley | Dr. GPCR Ecosystem
then Oliver has worked at the University of Geneva, where his research on peptide engineering and GPCR pharmacology
- Dr. Steven Foord | Dr. GPCR Ecosystem
He introduced molecular pharmacology to a wide range of the company's GPCR projects and was able to initiate
- Dr. Qing Fan | Dr. GPCR Ecosystem
Fan is currently an associate professor of Pharmacology and Pathology and Cell Biology at Columbia University
- Empowering Drug Discovery for the GPCR Community with Dr. Justin English | Dr. GPCR Ecosystem
His lab focuses on developing and innovating technologies to solve broad questions in pharmacology, with
- Dr. Terry Hébert | Dr. GPCR Ecosystem
Terry Hébert is a Professor within the Department of Pharmacology & Therapeutics at McGill University
- From Pipettes to Platforms The Evolution of GPCR Research | Dr. GPCR Ecosystem
and insights: https://www.ecosystem.drgpcr.com/gpcr-university-pricing #GPCR #DrGPCR #DrugDiscovery #Pharmacology
- Lighting up a native pancreatic islet isn’t just a technical win it’s a shift in what GPCR imaging can reveal | Dr. GPCR Ecosystem
receptor biology: Higher fidelity GPCR imaging without antibody variability Surface-pool selectivity — the pharmacologically
- CRO Advisory | Dr. GPCR Ecosystem
Any CRO focused on GPCRs, pharmacology, discovery biology, or antibody discovery—regardless of size or Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution
- VC Insights | Dr. GPCR Ecosystem
contingency-ready paths " Yamina brings scientific clarity, leadership, and precision execution to complex pharmacological Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution
- G Proteins and GPCRs in Cancer: Novel Precision Targeted and Immunotherapies
Gutkind is a Distinguished Professor and Chair of the Department of Pharmacology, School of Medicine,
- Dr. Jean-Philippe Pin | Dr. GPCR Ecosystem
using innovative approaches, including biosensors, cryo-EM, photoswitchable ligands, and nanobodies as pharmacological
- Dr. Maria Waldhoer | Dr. GPCR Ecosystem
She earned her M.Sc. in Zoology and Neurobiology before completing a Ph.D. in Biology and Pharmacology
- Cannabinoid compounds to augment L-DOPA treatment in Parkinson's Disease
In April 2009, he joined the Department of Pharmacology and Toxicology at University of Toronto and has
- ep 175 with jens carlsson clip 2 | Dr. GPCR Ecosystem
GPCR Podcast: model predict discover #DrGPCR #GPCR #CollaborationInScience #ComputationalChemistry #Pharmacology
- ep 175 with jens carlsson clip 3 | Dr. GPCR Ecosystem
screening compounds, or designing next-gen molecules, this insight reframes what “success” in computational pharmacology
- Dr. GPCR Board | Dr. GPCR Ecosystem
Trejo joined the faculty in the Department of Pharmacology at the University of North Carolina in 2000 and then moved to UC San Diego School Medicine, Department of Pharmacology in 2008, where she quickly In 2014, she was appointed Vice-Chair of the Department of Pharmacology. The long-term goal of Dr.
- Celtarys Research | Dr. GPCR Ecosystem
in a competitive manner and in a short time (<3 months), customized fluorescent ligands with optimal pharmacological Chemistry and Technology from the University of Bari and completed her PhD in Biomolecular Sciences in Pharmacology Probes Innovative fluorescent probes that de-risk the pre-clinical drug discovery phase with optimal pharmacological
- From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation | Dr. GPCR Ecosystem
strategic leaders seeking new drug development models Anyone curious about where AI meets molecular pharmacology rejection letter pivoted him into a PhD program at the University of Iowa, where he studied opioid pharmacology
- irreversible drugs post 2 | Dr. GPCR Ecosystem
www.ecosystem.drgpcr.com/post/beyond-clearance-the-strategic-power-of-irreversible-drug-binding #GPCR #DrGPCR #Pharmacology
- Dr. Antonella Di Pizio | Dr. GPCR Ecosystem
Join us to learn more about chemosensory GPCRs and how computational pharmacology can help better understand
- Dr. Kari Johnson | Dr. GPCR Ecosystem
Kari completed her Ph.D. in Pharmacology at Vanderbilt University before continuing her training as a
- Dr. Ross Cheloha | Dr. GPCR Ecosystem
Work in his independent laboratory is focused on developing new pharmacological tools via chemistry and
- Dr. Juan José Fung | Dr. GPCR Ecosystem
mainly focused on screening and assay development to bridge the gap between in vitro and in vivo GPCR pharmacology
- Dr. Daniel Isom | Dr. GPCR Ecosystem
Isom was recruited to the Molecular and Cellular Pharmacology Department at the University of Miami Miller
- GPCR Courses | Dr. GPCR Ecosystem
GPCR Drug Discovery Gain insider methods from the pioneers shaping biased signaling, assay design, and pharmacology—skills Terry Kenakin Terry's Corner Author of 'A Pharmacology Primer', the definitive GPCR reference used by Pioneer in quantitative pharmacology methods. Dr. Yamina Berchiche Dr. enough depth to satisfy the hunger for theory while being full of practical knowledge Anonymous The best pharmacology Also super-valuable for those of us learning how to teach pharmacology Anonymous Dr.
- Model. Predict. Discover. with Dr. Jens Carlsson | Dr. GPCR Ecosystem
Bridging computation, chemistry, and pharmacology is key to speeding up drug discovery. docking, molecular dynamics, and machine learning, Jens works at the intersection of computation and pharmacology
- Session VII | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Knowledge of the structural dynamics of this complex is limited and pharmacological and in vivo systems characterizing newly generated adhesion GPCR receptors in Drosophila as a model organism for future pharmacological
- Dr. Paul Insel | Dr. GPCR Ecosystem
on, Paul was hooked and has since studied receptor function in human physiology, receptor molecular pharmacology
- Dr. Kathryn E Livingston | Dr. GPCR Ecosystem
Kathryn obtained her BS in Chemistry from Carnegie Mellon University and went on to receive a Ph.D. in Pharmacology
- Chloe Hicks | Dr. GPCR Ecosystem
will graduate from Duke University this spring with a B.S degree in Biology with a concentration in Pharmacology






















